Toppila M, Ranta-Aho S, Kaarniranta K, Hytti M, Kauppinen A
Cells. 2024; 13(17.
PMID: 39273005
PMC: 11394619.
DOI: 10.3390/cells13171433.
Pan C, Wei Y, Dai J, Yang L, Ding Z, Wang X
Front Pharmacol. 2024; 15:1388253.
PMID: 39193327
PMC: 11347356.
DOI: 10.3389/fphar.2024.1388253.
Rasakanya T, Osuch E
Health SA. 2024; 29:2419.
PMID: 38962295
PMC: 11220136.
DOI: 10.4102/hsag.v29i0.2419.
Mihai I, Rudzitis-Auth J, Menger M, Laschke M
Int J Mol Sci. 2023; 24(18).
PMID: 37762161
PMC: 10531296.
DOI: 10.3390/ijms241813858.
Sonmez Unal G, Albak Y, Yurtcu N, Yildiz C, Cetin M, Dastan S
Turk J Obstet Gynecol. 2023; 20(3):219-226.
PMID: 37667560
PMC: 10478719.
DOI: 10.4274/tjod.galenos.2023.85616.
Gut microbiota and microbiota-derived metabolites promotes endometriosis.
Chadchan S, Naik S, Popli P, Talwar C, Putluri S, Ambati C
Cell Death Discov. 2023; 9(1):28.
PMID: 36693853
PMC: 9873805.
DOI: 10.1038/s41420-023-01309-0.
Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer.
Wang R, Li Y, Zhao Y, Shi F, Zhou Q, Wu J
Breast Cancer (Dove Med Press). 2022; 14:391-403.
PMID: 36482884
PMC: 9725923.
DOI: 10.2147/BCTT.S384702.
Metformin as a potential agent for modulating the faulty endometriotic mesenchymal stem cells: A case-control study.
Mashayekhi P, Noruzinia M, Khodaverdi S
Int J Reprod Biomed. 2022; 20(10):861-872.
PMID: 36381355
PMC: 9644643.
DOI: 10.18502/ijrm.v20i10.12270.
Metformin Alleviates Endometriosis and Potentiates Endometrial Receptivity Decreasing VEGF and MMP9 and Increasing Leukemia Inhibitor Factor and HOXA10.
Cheng J, Li C, Ying Y, Lv J, Qu X, McGowan E
Front Pharmacol. 2022; 13:750208.
PMID: 35273494
PMC: 8902464.
DOI: 10.3389/fphar.2022.750208.
Progesterone Actions and Resistance in Gynecological Disorders.
MacLean 2nd J, Hayashi K
Cells. 2022; 11(4).
PMID: 35203298
PMC: 8870180.
DOI: 10.3390/cells11040647.
Metformin as a Potential Treatment Option for Endometriosis.
Kimber-Trojnar Z, Dluski D, Wierzchowska-Opoka M, Ruszala M, Leszczynska-Gorzelak B
Cancers (Basel). 2022; 14(3).
PMID: 35158846
PMC: 8833654.
DOI: 10.3390/cancers14030577.
Changing prostaglandin E2 (PGE) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE receptor EP2 and EP4.
Huang Q, Liu X, Guo S
Reprod Med Biol. 2021; 21(1):e12426.
PMID: 34938150
PMC: 8660993.
DOI: 10.1002/rmb2.12426.
Polyphyllin I Inhibits -Induced IL-8 Secretion in HaCaT Cells by Downregulating the CD36/NOX1/ROS/NLRP3/IL-1 Pathway.
Yang S, Jiang Y, Yu X, Zhu L, Wang L, Mao J
Evid Based Complement Alternat Med. 2021; 2021:1821220.
PMID: 34603464
PMC: 8481039.
DOI: 10.1155/2021/1821220.
Metformin, the Rise of a New Medical Therapy for Endometriosis? A Systematic Review of the Literature.
Stochino-Loi E, Major A, Gillon T, Ayoubi J, Feki A, de Joliniere J
Front Med (Lausanne). 2021; 8:581311.
PMID: 34046415
PMC: 8144644.
DOI: 10.3389/fmed.2021.581311.
The Effect of Metformin on the Clinicopathological Features of Breast Cancer With Type 2 Diabetes.
Min W, Wang B, Guo A, Mao G, Zhao Y, Zhang S
World J Oncol. 2020; 11(1):23-32.
PMID: 32095186
PMC: 7011907.
DOI: 10.14740/wjon1242.
Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-kB activity.
Nguyen T, Ung T, Li S, Lian S, Xia Y, Park S
Sci Rep. 2019; 9(1):2003.
PMID: 30765814
PMC: 6376015.
DOI: 10.1038/s41598-019-38778-2.
Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.
Rendic S, Guengerich F
Drug Metab Rev. 2019; 50(3):256-342.
PMID: 30717606
PMC: 6421578.
DOI: 10.1080/03602532.2018.1483401.
Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome.
Zhang Y, Hu M, Meng F, Sun X, Xu H, Zhang J
EBioMedicine. 2017; 18:157-170.
PMID: 28336389
PMC: 5405166.
DOI: 10.1016/j.ebiom.2017.03.023.
Obesity-associated NLRC4 inflammasome activation drives breast cancer progression.
Kolb R, Phan L, Borcherding N, Liu Y, Yuan F, Janowski A
Nat Commun. 2016; 7:13007.
PMID: 27708283
PMC: 5059727.
DOI: 10.1038/ncomms13007.
Metformin suppresses pancreatic tumor growth with inhibition of NFκB/STAT3 inflammatory signaling.
Tan X, Bhattacharyya K, Dutta S, Bamlet W, Rabe K, Wang E
Pancreas. 2015; 44(4):636-47.
PMID: 25875801
PMC: 4399019.
DOI: 10.1097/MPA.0000000000000308.